- Home
- HIT vs NAUT Comparison
HIT vs NAUT Comparison
Compare HIT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIT | NAUT |
|---|---|---|
| Founded | 1964 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.4M | 256.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | HIT | NAUT |
|---|---|---|
| Price | $1.07 | $1.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 488.0K | 337.1K |
| Earning Date | 11-10-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $30,723,490.00 | N/A |
| Revenue This Year | $70.02 | N/A |
| Revenue Next Year | $44.08 | N/A |
| P/E Ratio | $50.12 | ★ N/A |
| Revenue Growth | ★ 55.15 | N/A |
| 52 Week Low | $0.51 | $0.62 |
| 52 Week High | $7.59 | $2.54 |
Technical Indicators
Market Signals| Indicator | HIT | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 29.75 | 48.53 |
| Support Level | $1.04 | $1.96 |
| Resistance Level | $1.16 | $2.13 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 5.63 | 5.86 |
Price Performance
Historical ComparisonAbout HIT Health In Tech Inc.
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.